126 related articles for article (PubMed ID: 34565708)
1. Combination Therapy With Bortezomib in Renal Medullary Carcinoma: A Case Series.
Ryan A; Tawagi K; VanderVeen N; Matrana M; Vasquez R
Clin Genitourin Cancer; 2021 Dec; 19(6):e395-e400. PubMed ID: 34565708
[TBL] [Abstract][Full Text] [Related]
2. Platinum plus bortezomib for the treatment of pediatric renal medullary carcinoma: Two cases.
Carden MA; Smith S; Meany H; Yin H; Alazraki A; Rapkin LB
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28052556
[TBL] [Abstract][Full Text] [Related]
3. Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma.
Beckermann KE; Jolly PC; Kim JY; Bordeaux J; Puzanov I; Rathmell WK; Johnson DB
J Immunother Cancer; 2017; 5():1. PubMed ID: 28105368
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic approach guided by genetic alteration: use of MTOR inhibitor in renal medullary carcinoma with loss of PTEN expression.
Lipkin JS; Rizvi SM; Gatalica Z; Sarwani NE; Holder SL; Kaag M; Drabick JJ; Joshi M
Cancer Biol Ther; 2015; 16(1):28-33. PubMed ID: 25692619
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24).
Thibault C; Fléchon A; Albiges L; Joly C; Barthelemy P; Gross-Goupil M; Chevreau C; Coquan E; Rolland F; Laguerre B; Gravis G; Pécuchet N; Elaidi RT; Timsit MO; Brihoum M; Auclin E; de Reyniès A; Allory Y; Oudard S
Eur J Cancer; 2023 Jun; 186():83-90. PubMed ID: 37054556
[TBL] [Abstract][Full Text] [Related]
6. Complete response to carboplatin, gemcitabine, and paclitaxel in a patient with advanced metastatic renal medullary carcinoma.
Walsh A; Kelly DR; Vaid YN; Hilliard LM; Friedman GK
Pediatr Blood Cancer; 2010 Dec; 55(6):1217-20. PubMed ID: 20979179
[TBL] [Abstract][Full Text] [Related]
7. Significant responses to platinum-based chemotherapy in renal medullary carcinoma.
Strouse JJ; Spevak M; Mack AK; Arceci RJ; Small D; Loeb DM
Pediatr Blood Cancer; 2005 Apr; 44(4):407-11. PubMed ID: 15602719
[TBL] [Abstract][Full Text] [Related]
8. Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments.
Wei D; Yang Y; Ricketts CJ; Vocke CD; Ball MW; Sourbier C; Wangsa D; Wangsa D; Guha R; Zhang X; Wilson K; Chen L; Meltzer PS; Ried T; Thomas CJ; Merino MJ; Linehan WM
Genes Chromosomes Cancer; 2020 Aug; 59(8):472-483. PubMed ID: 32259323
[TBL] [Abstract][Full Text] [Related]
9. Cystic presentation of a renal medullary carcinoma in a young woman.
Levi Sandri GB; Spoletini G; Lai Q; Mennini G; Rossi M
Urologia; 2015; 82(2):124-6. PubMed ID: 25451881
[TBL] [Abstract][Full Text] [Related]
10. Renal medullary carcinoma response to chemotherapy: a referral center experience in Brazil.
Maroja Silvino MC; Venchiarutti Moniz CM; Munhoz Piotto GH; Siqueira S; Galapo Kann A; Dzik C
Rare Tumors; 2013; 5(3):e44. PubMed ID: 24179656
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma.
Wilson NR; Wiele AJ; Surasi DS; Rao P; Sircar K; Tamboli P; Shah AY; Genovese G; Karam JA; Wood CG; Tannir NM; Msaouel P
Clin Genitourin Cancer; 2021 Dec; 19(6):e401-e408. PubMed ID: 34625389
[TBL] [Abstract][Full Text] [Related]
12. Renal medullary carcinoma: molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy.
Schaeffer EM; Guzzo TJ; Furge KA; Netto G; Westphal M; Dykema K; Yang X; Zhou M; Teh BT; Pavlovich CP
BJU Int; 2010 Jul; 106(1):62-5. PubMed ID: 20002663
[TBL] [Abstract][Full Text] [Related]
13. Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study.
Shah AY; Karam JA; Malouf GG; Rao P; Lim ZD; Jonasch E; Xiao L; Gao J; Vaishampayan UN; Heng DY; Plimack ER; Guancial EA; Fung C; Lowas SR; Tamboli P; Sircar K; Matin SF; Kimryn Rathmell W; Wood CG; Tannir NM
BJU Int; 2017 Dec; 120(6):782-792. PubMed ID: 27860149
[TBL] [Abstract][Full Text] [Related]
14. Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma.
Msaouel P; Hong AL; Mullen EA; Atkins MB; Walker CL; Lee CH; Carden MA; Genovese G; Linehan WM; Rao P; Merino MJ; Grodman H; Dome JS; Fernandez CV; Geller JI; Apolo AB; Daw NC; Hodges HC; Moxey-Mims M; Wei D; Bottaro DP; Staehler M; Karam JA; Rathmell WK; Tannir NM
Clin Genitourin Cancer; 2019 Feb; 17(1):1-6. PubMed ID: 30287223
[TBL] [Abstract][Full Text] [Related]
15. Renal Medullary Carcinoma and Sickle Cell Trait: A Push for Early Diagnosis and Intervention Report of Two Cases.
Carter SA; Walker AN
J Natl Med Assoc; 2017 Spring; 109(1):63-65. PubMed ID: 28259220
[TBL] [Abstract][Full Text] [Related]
16. [Renal medullary carcinoma: remission with gemcitabine-cisplatin and review of therapeutic perspectives].
Diao B; Paule B; Esquivel S; Abbou CC; Salomon L; De La Taille A
Prog Urol; 2010 Jul; 20(7):538-41. PubMed ID: 20656278
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study.
Geller JI; Cost NG; Chi YY; Tornwall B; Cajaiba M; Perlman EJ; Kim Y; Mullen EA; Glick RD; Khanna G; Daw NC; Ehrlich P; Fernandez CV; Dome JS;
Cancer; 2020 Dec; 126(23):5156-5164. PubMed ID: 32926409
[TBL] [Abstract][Full Text] [Related]
18. Collecting duct carcinoma of the kidney: a clinicopathological study of 9 cases.
Peyromaure M; Thiounn N; Scotté F; Vieillefond A; Debré B; Oudard S
J Urol; 2003 Oct; 170(4 Pt 1):1138-40. PubMed ID: 14501710
[TBL] [Abstract][Full Text] [Related]
19. High-dose-intensity MVAC for Advanced Renal Medullary Carcinoma: Report of Three Cases and Literature Review.
Rathmell WK; Monk JP
Urology; 2008 Sep; 72(3):659-63. PubMed ID: 18649931
[TBL] [Abstract][Full Text] [Related]
20. A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321.
Zhao Y; Foster NR; Meyers JP; Thomas SP; Northfelt DW; Rowland KM; Mattar BI; Johnson DB; Molina JR; Mandrekar SJ; Schild SE; Bearden JD; Aubry MC; Adjei AA
J Thorac Oncol; 2015 Jan; 10(1):172-80. PubMed ID: 25247339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
